|
2021-12-16 |
2021-12-15 |
B
Purchase
|
Koconis John
CEO & President
Executive Director
|
20,000
+inf%
0.38
USD 7,686
|
20,000
+inf%
|
0.38
|
USD 7,686
|
|
|
2021-11-24 |
2021-11-23 |
B
Purchase
|
Sitar Edward J
Non-Executive Director
|
15,000
+inf%
0.46
USD 6,900
|
15,000
+inf%
|
0.46
|
USD 6,900
|
|
|
2021-11-24 |
2021-11-23 |
B
Purchase
|
Mendelsohn Alan
Chief Medical Officer
Officer
|
10,000
+inf%
0.47
USD 4,700
|
10,000
+inf%
|
0.47
|
USD 4,700
|
|
|
2021-08-20 |
2021-08-20 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
50,000
-1.1%
0.91
USD 45,395
|
50,000
-1.1%
|
0.91
|
USD 45,395
|
|
|
2021-08-20 |
2021-08-19 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
50,000
-1.1%
0.95
USD 47,700
|
50,000
-1.1%
|
0.95
|
USD 47,700
|
|
|
2021-08-20 |
2021-08-18 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
75,000
-1.6%
1.00
USD 75,075
|
75,000
-1.6%
|
1.00
|
USD 75,075
|
|
|
2021-06-10 |
2021-06-10 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
185,229
-3.7%
1.26
USD 233,926
|
185,229
-3.7%
|
1.26
|
USD 233,926
|
|
|
2021-06-10 |
2021-06-09 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
96,481
-1.9%
1.27
USD 122,907
|
96,481
-1.9%
|
1.27
|
USD 122,907
|
|
|
2021-06-10 |
2021-06-08 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
305,540
-5.7%
1.29
USD 393,383
|
305,540
-5.7%
|
1.29
|
USD 393,383
|
|
|
2021-06-02 |
2021-06-02 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
9,879
-0.2%
1.26
USD 12,448
|
9,879
-0.2%
|
1.26
|
USD 12,448
|
|
|
2021-06-02 |
2021-06-01 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
8,670
-0.2%
1.26
USD 10,952
|
8,670
-0.2%
|
1.26
|
USD 10,952
|
|
|
2021-06-02 |
2021-05-28 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
47,736
-0.9%
1.27
USD 60,620
|
47,736
-0.9%
|
1.27
|
USD 60,620
|
|
|
2021-05-13 |
2021-03-03 |
B
Purchase
|
Mendelsohn Alan
Chief Medical Officer
Officer
|
1,988
+inf%
2.17
USD 4,314
|
1,988
+inf%
|
2.17
|
USD 4,314
|
|
|
2020-09-16 |
2020-09-16 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
100,694
-1.8%
1.03
USD 103,695
|
100,694
-1.8%
|
1.03
|
USD 103,695
|
|
|
2020-09-16 |
2020-09-15 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
87,060
-1.5%
1.03
USD 89,550
|
87,060
-1.5%
|
1.03
|
USD 89,550
|
|
|
2020-09-16 |
2020-09-14 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
455
-0.0%
1.03
USD 469
|
455
-0.0%
|
1.03
|
USD 469
|
|
|
2020-09-14 |
2020-09-11 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
7,483
-0.1%
1.03
USD 7,710
|
7,483
-0.1%
|
1.03
|
USD 7,710
|
|
|
2020-09-14 |
2020-09-10 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
32,943
-0.6%
1.04
USD 34,379
|
32,943
-0.6%
|
1.04
|
USD 34,379
|
|
|
2020-02-12 |
2020-02-10 |
S
Sale
|
Timber Pharmaceuticals LLC
Large shareholder
|
55,008
-2.4%
0.01
USD 550
|
55,008
-2.4%
|
0.01
|
USD 550
|
|
|
2020-02-12 |
2020-02-10 |
S
Sale
|
TardiMed Sciences LLC
Large shareholder
|
55,008
-2.4%
0.01
USD 550
|
55,008
-2.4%
|
0.01
|
USD 550
|
|
|
2019-06-27 |
2019-06-25 |
S
Sale
|
Vivo Capital VIII, LLC
Large shareholder
|
327,870
-50.8%
1.02
USD 334,427
|
327,870
-50.8%
|
1.02
|
USD 334,427
|
|
|
2019-01-25 |
2019-01-23 |
S
Sale
|
Krammer Anja B
Non-Executive Director
|
115,874
-5.8%
0.11
USD 12,746
|
115,874
-5.8%
|
0.11
|
USD 12,746
|
|
|
2018-10-22 |
2018-10-22 |
S
Sale
|
Morlock Stephen
Non-Executive Director
|
251,071
-100.0%
0.18
USD 45,193
|
251,071
-100.0%
|
0.18
|
USD 45,193
|
|
|
2018-10-22 |
2018-10-22 |
S
Sale
|
Morlock Stephen
Non-Executive Director
|
220,766
-100.0%
0.18
USD 39,738
|
220,766
-100.0%
|
0.18
|
USD 39,738
|
|
|
2018-10-22 |
2018-10-19 |
S
Sale
|
Morlock Stephen
Non-Executive Director
|
214,091
-49.2%
0.18
USD 38,536
|
214,091
-49.2%
|
0.18
|
USD 38,536
|
|
|
2018-10-22 |
2018-10-18 |
S
Sale
|
Morlock Stephen
Non-Executive Director
|
439,099
-50.2%
0.19
USD 83,429
|
439,099
-50.2%
|
0.19
|
USD 83,429
|
|
|
2018-10-12 |
2018-10-12 |
S
Sale
|
Krammer Anja B
Non-Executive Director
|
297,500
-12.9%
0.19
USD 56,525
|
297,500
-12.9%
|
0.19
|
USD 56,525
|
|
|
2018-10-12 |
2018-10-11 |
S
Sale
|
Krammer Anja B
Non-Executive Director
|
100,000
-4.2%
0.19
USD 19,000
|
100,000
-4.2%
|
0.19
|
USD 19,000
|
|
|
2018-10-12 |
2018-10-10 |
S
Sale
|
Krammer Anja B
Non-Executive Director
|
102,500
-4.1%
0.19
USD 19,475
|
102,500
-4.1%
|
0.19
|
USD 19,475
|
|
|
2018-09-20 |
2018-09-19 |
B
Purchase
|
Tierney David S
CEO
Executive Director
|
100,000
+1.4%
0.20
USD 20,250
|
100,000
+1.4%
|
0.20
|
USD 20,250
|
|
|
2018-03-09 |
2018-03-07 |
S
Sale
|
Vivo Capital VIII, LLC
Large shareholder
|
2,000,000
-11.0%
0.36
USD 720,000
|
2,000,000
-11.0%
|
0.36
|
USD 720,000
|
|
|
2017-11-27 |
2017-11-24 |
B
Purchase
|
Morlock Stephen
|
330,000
+60.7%
0.15
USD 49,500
|
330,000
+60.7%
|
0.15
|
USD 49,500
|
|
|
2017-11-13 |
2017-11-09 |
S
Sale
|
Vivo Capital VIII, LLC
Large shareholder
|
296,394
-2.1%
0.20
USD 59,279
|
296,394
-2.1%
|
0.20
|
USD 59,279
|
|
|
2017-08-03 |
2017-08-01 |
B
Purchase
|
FRANKLIN RESOURCES INC
Large shareholder
|
250,000
+2.6%
0.34
USD 84,300
|
250,000
+2.6%
|
0.34
|
USD 84,300
|
|
|
2017-05-01 |
2017-04-28 |
B
Purchase
|
Vivo Capital Fund VIII, L.P.
Large shareholder
|
1,282,052
+10.0%
0.78
USD 1,000,001
|
1,282,052
+10.0%
|
0.78
|
USD 1,000,001
|
|
|
2016-11-30 |
2016-11-22 |
B
Purchase
|
FRANKLIN RESOURCES INC
Large shareholder
|
4,375,000
0.00
USD 0
|
4,375,000
|
0.00
|
USD 0
|
|
|
2016-08-16 |
2016-08-15 |
B
Purchase
|
FRANKLIN RESOURCES INC
Large shareholder
|
484,615
+10.4%
0.65
USD 315,000
|
484,615
+10.4%
|
0.65
|
USD 315,000
|
|
|
2016-03-31 |
2016-03-29 |
B
Purchase
|
FRANKLIN RESOURCES INC
Large shareholder
|
540,000
+13.2%
1.20
USD 648,000
|
540,000
+13.2%
|
1.20
|
USD 648,000
|
|
|
2016-01-15 |
2016-01-14 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
5,500
+2.2%
1.53
USD 8,415
|
5,500
+2.2%
|
1.53
|
USD 8,415
|
|
|
2016-01-15 |
2016-01-13 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
6,500
+2.7%
1.52
USD 9,880
|
6,500
+2.7%
|
1.52
|
USD 9,880
|
|
|
2016-01-12 |
2016-01-12 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
3,000
+1.3%
1.63
USD 4,890
|
3,000
+1.3%
|
1.63
|
USD 4,890
|
|
|
2016-01-12 |
2016-01-11 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
3,000
+1.3%
1.43
USD 4,290
|
3,000
+1.3%
|
1.43
|
USD 4,290
|
|
|
2016-01-11 |
2016-01-07 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
5,000
+2.2%
1.47
USD 7,350
|
5,000
+2.2%
|
1.47
|
USD 7,350
|
|
|
2015-10-15 |
2015-10-15 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
3,000
+1.3%
1.23
USD 3,690
|
3,000
+1.3%
|
1.23
|
USD 3,690
|
|
|
2015-10-15 |
2015-10-14 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
2,000
+0.9%
1.25
USD 2,500
|
2,000
+0.9%
|
1.25
|
USD 2,500
|
|
|
2015-10-13 |
2015-10-09 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
2,000
+0.9%
1.19
USD 2,380
|
2,000
+0.9%
|
1.19
|
USD 2,380
|
|
|
2015-10-13 |
2015-10-09 |
B
Purchase
|
Morlock Stephen
Non-Executive Director
|
1,000
+0.5%
1.26
USD 1,260
|
1,000
+0.5%
|
1.26
|
USD 1,260
|
|
